- ►rh.dk [PDF] LL Baggio, DJ Drucker - Gastroenterology, 2007 - Elsevier This review focuses on the mechanisms regulating the synthesis, secretion, biological
actions, and therapeutic relevance of the incretin peptides glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). The published literature was ... Cited by 179 - Related articles - All 25 versions
JJ Meier, A Gethmann, O Götze, B Gallwitz, JJ Holst, … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: Diabetic dyslipidaemia con- tributes to the excess morbidity and mortality
in patients with type 2 diabetes. Exogenous glucagon-like peptide 1 (GLP-1) lowers postprandial
glycaemia predominantly by slowing gastric emptying. Therefore, the effects of GLP-1 on ... Cited by 36 - Related articles - BL Direct - All 3 versions
- ►endojournals.org D Gentilcore, R Chaikomin, KL Jones, A Russo, … - Journal of Clinical …, 2006 - Endocrine Soc Context: Gastric emptying (GE) is a major determinant of postprandial glycemia. Because the
presence of fat in the small intestine inhibits GE, ingestion of fat may attenuate the glycemic response
to carbohydrate. ... Objective: The objective of this study was to evaluate the effect of ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►endojournals.org TJ Little, AN Pilichiewicz, A Russo, L Phillips, … - Journal of Clinical …, 2006 - Endocrine Soc Results: GLP-1 0.3 and 0.9 slowed GE of solid (intragastric retention at t = 100 min; saline: 28
± 5%; GLP-1 0.3: 53 ± 6%; GLP-1 0.9: 58 ± 7%; P < 0.001) and liquid (time for 50% of the liquid
to empty, saline: 28 ± 2 min; GLP-1 0.3: 42 ± 7 min; GLP-1 0.9: 50 ± 9 min; P < 0.001). ... Cited by 27 - Related articles - BL Direct - All 4 versions
JJ Meier, MA Nauck - Current Diabetes Reports, 2006 - Springer The incretin hormones gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1
(GLP-1) are released in response to nutrient ingestion and potentiate glucose- stimulated insulin
secretion from pancreatic β cells. The augmentation of postprandial insulin secretion by ... Cited by 20 - Related articles - BL Direct - All 2 versions
- ►nih.gov [PDF] M Horowitz, MA Nauck - British Medical Journal, 2006 - gut.bmj.com 18 Lenz HJ, Burlage M, Raedler A, et al. Central nervous system effects of corticotropin-releasing
factor on gastrointestinal transit in the rat. Gastroenterology 1988;94:598–602. 19 Saito K, Kasai
T, Nagura Y, et al. Corticotropin- releasing hormone receptor-1 antagonist blocks ... Cited by 15 - Related articles - BL Direct - All 8 versions
- ►endocrinology-journals.org TH Claus, CQ Pan, JM Buxton, L Yang, JC … - Journal of …, 2007 - Soc Endocrinology Type 2 diabetes is characterized by reduced insulin secretion from the pancreas and overproduction
of glucose by the liver. Glucagon-like peptide-1 (GLP-1) promotes glucose-dependent insulin
secretion from the pancreas, while glucagon promotes glucose output from the liver. ... Cited by 10 - Related articles - BL Direct - All 4 versions
- ►endojournals.org [PDF] TJ Little, AN Pilichiewicz, A Russo, L Phillips, … - Journal of Clinical …, 2006 - Endocrine Soc Page 1. EFFECTS OF INTRAVENOUS GLP-1 ON GASTRIC EMPTYING AND
INTRAGASTRIC DISTRIBUTION IN HEALTHY SUBJECTS – RELATIONSHIPS WITH
POSTPRANDIAL GLYCEMIC AND INSULINEMIC RESPONSES ... Cited by 8 - Related articles
- ►physiology.org CN Andrews, AE Bharucha, M Camilleri, … - American Journal of …, 2007 - Am Physiological Soc The incretin glucagon-like peptide-1 (GLP-1), which is used to treat diabetes mellitus, delays
gastric emptying by inhibiting vagal activity. GLP-1 also increases fasting and postprandial gastric
volume in humans. On the basis of animal studies, we hypothesized that nitric oxide ... Cited by 6 - Related articles - BL Direct - All 6 versions
- ►endojournals.org M Ellrichmann, M Kapelle, PR Ritter, JJ Holst, … - Journal of Clinical …, 2008 - Endocrine Soc Introduction: Intestinal lipase inhibition using tetrahydrolipstatin (Orlistat) has been widely used
in the pharmacotherapy of morbid obesity. However, the effects of Orlistat on the secretion of
appetite regulating gastrointestinal hormones and appetite sensations are still debated. ... Cited by 5 - Related articles - All 5 versions
